OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
OTLK stock results show that Outlook Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
The post OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace